Cargando…

New method for determining breast cancer recurrence-free survival using routinely collected real-world health data

BACKGROUND: In cancer survival analyses using population-based data, researchers face the challenge of ascertaining the timing of recurrence. We previously developed algorithms to identify recurrence of breast cancer. This is a follow-up study to detect the timing of recurrence. METHODS: Health even...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Hyunmin, Lu, Mingshan, Quan, May Lynn, Cheung, Winson Y., Kong, Shiying, Lupichuk, Sasha, Feng, Yuanchao, Xu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925135/
https://www.ncbi.nlm.nih.gov/pubmed/35296284
http://dx.doi.org/10.1186/s12885-022-09333-6
_version_ 1784670005256781824
author Jung, Hyunmin
Lu, Mingshan
Quan, May Lynn
Cheung, Winson Y.
Kong, Shiying
Lupichuk, Sasha
Feng, Yuanchao
Xu, Yuan
author_facet Jung, Hyunmin
Lu, Mingshan
Quan, May Lynn
Cheung, Winson Y.
Kong, Shiying
Lupichuk, Sasha
Feng, Yuanchao
Xu, Yuan
author_sort Jung, Hyunmin
collection PubMed
description BACKGROUND: In cancer survival analyses using population-based data, researchers face the challenge of ascertaining the timing of recurrence. We previously developed algorithms to identify recurrence of breast cancer. This is a follow-up study to detect the timing of recurrence. METHODS: Health events that signified recurrence and timing were obtained from routinely collected administrative data. The timing of recurrence was estimated by finding the timing of key indicator events using three different algorithms, respectively. For validation, we compared algorithm-estimated timing of recurrence with that obtained from chart-reviewed data. We further compared the results of cox regressions models (modeling recurrence-free survival) based on the algorithms versus chart review. RESULTS: In total, 598 breast cancer patients were included. 121 (20.2%) had recurrence after a median follow-up of 4 years. Based on the high accuracy algorithm for identifying the presence of recurrence (with 94.2% sensitivity and 79.2% positive predictive value), the majority (64.5%) of the algorithm-estimated recurrence dates fell within 3 months of the corresponding chart review determined recurrence dates. The algorithm estimated and chart-reviewed data generated Kaplan–Meier (K-M) curves and Cox regression results for recurrence-free survival (hazard ratios and P-values) were very similar. CONCLUSION: The proposed algorithms for identifying the timing of breast cancer recurrence achieved similar results to the chart review data and were potentially useful in survival analysis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09333-6.
format Online
Article
Text
id pubmed-8925135
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89251352022-03-23 New method for determining breast cancer recurrence-free survival using routinely collected real-world health data Jung, Hyunmin Lu, Mingshan Quan, May Lynn Cheung, Winson Y. Kong, Shiying Lupichuk, Sasha Feng, Yuanchao Xu, Yuan BMC Cancer Research BACKGROUND: In cancer survival analyses using population-based data, researchers face the challenge of ascertaining the timing of recurrence. We previously developed algorithms to identify recurrence of breast cancer. This is a follow-up study to detect the timing of recurrence. METHODS: Health events that signified recurrence and timing were obtained from routinely collected administrative data. The timing of recurrence was estimated by finding the timing of key indicator events using three different algorithms, respectively. For validation, we compared algorithm-estimated timing of recurrence with that obtained from chart-reviewed data. We further compared the results of cox regressions models (modeling recurrence-free survival) based on the algorithms versus chart review. RESULTS: In total, 598 breast cancer patients were included. 121 (20.2%) had recurrence after a median follow-up of 4 years. Based on the high accuracy algorithm for identifying the presence of recurrence (with 94.2% sensitivity and 79.2% positive predictive value), the majority (64.5%) of the algorithm-estimated recurrence dates fell within 3 months of the corresponding chart review determined recurrence dates. The algorithm estimated and chart-reviewed data generated Kaplan–Meier (K-M) curves and Cox regression results for recurrence-free survival (hazard ratios and P-values) were very similar. CONCLUSION: The proposed algorithms for identifying the timing of breast cancer recurrence achieved similar results to the chart review data and were potentially useful in survival analysis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09333-6. BioMed Central 2022-03-16 /pmc/articles/PMC8925135/ /pubmed/35296284 http://dx.doi.org/10.1186/s12885-022-09333-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jung, Hyunmin
Lu, Mingshan
Quan, May Lynn
Cheung, Winson Y.
Kong, Shiying
Lupichuk, Sasha
Feng, Yuanchao
Xu, Yuan
New method for determining breast cancer recurrence-free survival using routinely collected real-world health data
title New method for determining breast cancer recurrence-free survival using routinely collected real-world health data
title_full New method for determining breast cancer recurrence-free survival using routinely collected real-world health data
title_fullStr New method for determining breast cancer recurrence-free survival using routinely collected real-world health data
title_full_unstemmed New method for determining breast cancer recurrence-free survival using routinely collected real-world health data
title_short New method for determining breast cancer recurrence-free survival using routinely collected real-world health data
title_sort new method for determining breast cancer recurrence-free survival using routinely collected real-world health data
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925135/
https://www.ncbi.nlm.nih.gov/pubmed/35296284
http://dx.doi.org/10.1186/s12885-022-09333-6
work_keys_str_mv AT junghyunmin newmethodfordeterminingbreastcancerrecurrencefreesurvivalusingroutinelycollectedrealworldhealthdata
AT lumingshan newmethodfordeterminingbreastcancerrecurrencefreesurvivalusingroutinelycollectedrealworldhealthdata
AT quanmaylynn newmethodfordeterminingbreastcancerrecurrencefreesurvivalusingroutinelycollectedrealworldhealthdata
AT cheungwinsony newmethodfordeterminingbreastcancerrecurrencefreesurvivalusingroutinelycollectedrealworldhealthdata
AT kongshiying newmethodfordeterminingbreastcancerrecurrencefreesurvivalusingroutinelycollectedrealworldhealthdata
AT lupichuksasha newmethodfordeterminingbreastcancerrecurrencefreesurvivalusingroutinelycollectedrealworldhealthdata
AT fengyuanchao newmethodfordeterminingbreastcancerrecurrencefreesurvivalusingroutinelycollectedrealworldhealthdata
AT xuyuan newmethodfordeterminingbreastcancerrecurrencefreesurvivalusingroutinelycollectedrealworldhealthdata